Immune Control is founded on a novel observation-the neurotransmitter, serotonin, is essential for the replication of activated immune cells. When serotonin receptors on immune cells are blocked, the cells die. The Company is thus pursuing specific serotonin antagonists for use against lymphoproliferative cancers, autoimmune diseases, and transplant rejection.